Reversible Eltrombopag-Associated Bone Marrow Fibrosis With Hematologic Recovery After Drug Withdrawal in ASXL1-Mutated Hypoplastic Myelodysplastic Syndrome: A Case Report.

Promacta (eltrombopag) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42781284

Chisato Ohe; Ikuo Matsuda; Kyoko Yoshihara; Mami Samori; Naru Tomigaki; Saki Takahashi; Satoshi Yoshihara; Yasuhito Nannya

Sep 25, 2026